LifeMD
LFMD

LifeMD (LFMD) analyst forecast and price target

Analyst forecast

Buy

Consensus of 8 analyst ratings

Buy
8
Hold
0
Sell
0
Average price target
$8.67+178.22% vs. last price
Last $3.12
Low $8.00High $9.00

Based on 3 analyst targets

Recent analyst ratings

FirmActionRatingPrice targetDate
HC Wainwright & Co.MaintainedBuy$9.00 from $10.00Aug 7, 2026
BTIGMaintainedBuy$9.00 from $10.00Aug 6, 2026
B. Riley SecuritiesMaintainedBuy$8.00 from $10.00Aug 6, 2026
HC Wainwright & Co.MaintainedBuy$10.00May 26, 2026
BTIGMaintainedBuy$10.00May 4, 2026
MizuhoUpgradedNeutral → Outperform$8.00 from $6.00Mar 16, 2026
Freedom Capital MarketsMaintainedBuy$10.00 from $8.00Mar 12, 2026
HC Wainwright & Co.MaintainedBuy$10.00 from $9.00Mar 11, 2026
BTIGMaintainedBuy$10.00Mar 10, 2026
KeybancMaintainedOverweight$8.00 from $12.00Nov 19, 2025
HC Wainwright & Co.MaintainedBuy$9.00 from $13.00Nov 19, 2025
MizuhoMaintainedNeutral$6.00 from $8.00Nov 19, 2025
BTIGMaintainedBuy$10.00 from $18.00Nov 18, 2025
B. Riley SecuritiesMaintainedBuy$10.00 from $12.00Nov 18, 2025
Lake StreetMaintainedBuy$8.00 from $14.00Nov 18, 2025
HC Wainwright & Co.MaintainedBuy$13.00 from $14.00Aug 7, 2025
KeybancMaintainedOverweight$12.00 from $14.00Aug 6, 2025
Lake StreetMaintainedBuy$14.00 from $18.00Aug 6, 2025
KeybancMaintainedOverweight$14.00 from $12.00Jul 14, 2025
Lake StreetMaintainedBuy$18.00 from $12.00Jul 10, 2025

Frequently asked questions

  • What is the price target for LFMD stock?

    The average 12-month analyst price target for LifeMD (LFMD) is $8.67, with a high estimate of $9.00 and a low of $8.00, across 3 analysts.

  • Is LFMD a buy, sell, or hold?

    Analysts covering LifeMD currently average a Buy rating: 8 buy, 0 hold and 0 sell, from 8 analysts. Ratings reflect analyst opinion, not investment advice.

  • What upside do analysts see for LFMD?

    The average price target of $8.67 implies 178.22% upside from the last price of $3.12.

  • What is the latest analyst rating on LFMD?

    On Aug 7, 2026, HC Wainwright & Co. maintained LifeMD at Buy with a price target of $9.00.

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.